medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2008, Number 4

<< Back Next >>

Arch Neurocien 2008; 13 (4)

Multiple brain infarcts due to inmonoglobulin at low dosis in a patient whit guillain barre syndrome

Novarro-Escudero N, Arauz-Góngora A, Merlos-Benítez M

Language: Spanish
References: 9
Page: 255-257
PDF size: 95.27 Kb.


ABSTRACT

Sixty years old woman with a Guillain Barre syndrome (GBS) had multiple brain infarcts because the administration of intravenous inmonoglobulin (IVIg) four dosis of 5 grams a day were given. Cuadriparesis, stupor and visual alterations apeared 3 days alter the medication was given magnetic resonante demonstrated the multiple infarcts. The coexistence of both diseases might be posible but in this case the immediately aparence makes the cause efecto the most posible explanation.


REFERENCES

  1. Wiles CM, Brown P, Chapel H, Guerrini R, Hughes RAC, MartinTD, et al. Intravenous immunoglobulin in neurological disease: a specialist review. J Neurol Neurosurg Psychiatry 2002;72:440-8.

  2. Dalakas MC, Clark WM. Stroke, Thromboembolic events, and IVIC: rare incidents blemish an excellent safety record. Neurology 2003;60:1736-7.

  3. Caress J, Cartwright MS, Donofrio PD, Peacock Jr JE. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 2003;60:1822-4.

  4. Turner B, Wills AJ. Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2000; 68:790-1.

  5. Doss-Esper C, Singhal A, Smith M, Henderson G. Reversible Posterior Leukoencephalopathy, Cerebral Vasoconstriction, and stroke after intravenous immunoglobulin therapy in Guillain-Barré syndrome. J Neuroimag 2005; 15(2),188-92.

  6. Evangelou N, Littlewood T, Anslow P, Chapel H. Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk–benefit assessment for immunoglobulin treatment. J Clin Pathol 2003; 56: 308-9.

  7. Okuda D, Flaster M, Frey J, Sivakumar M. Arterial thrombosis induced by IVIg and its treatment with tPA. Neurol 2003; 60:1825-6.

  8. Hinchey J, Caves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior luekoencephalopathy syndrome. NEJM 1996; 334:494-500.

  9. Van Diest D, Van Goethem JWM, Vercruyssen A, Jadoul C, Cras P. Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: Coincidence or causative relation?. Clin Neurol Neurosurg 2007;109:58-62.




2020     |     www.medigraphic.com